Search
A powerful therapy called an antibody-drug conjugate has been approved by the FDA for more people with bladder cancer.
Learn about MSK’s Adolescent and Young Adult program, which is uniquely positioned to help patients like Danielle Leventhal.
For cancer in the liver, interventional radiology techniques can be used to destroy tumors while minimizing damage to healthy liver tissue.
Learn how Kéara was able to maintain her quality of life after treatment for triple negative breast cancer.
Scientists are learning how tumors develop resistance to drugs — and what can be done about it.
Meet Victoria “Vikki” Mills, Associate Director of Research Administration Operations at Memorial Sloan Kettering, who is deeply satisfied with her work and delighted with her family, which will soon expand — Vikki is expecting her second child in August with her fiancée, Shauna.
Scientists at Sloan Kettering Institute have discovered that the α6ß4 integrin, one of several receptor proteins, plays a key role in signaling for the formation of new blood vessels for a tumor, a process called tumor angiogenesis. By blocking the signaling activity of the α6ß4 subunit of this integrin on vascular cells, researchers found they could slow the growth of tumors.
MSK surgeon James Eastham explains the pros and cons of PSA testing and weighs in on a new US Preventive Services Task Force guideline.
Researchers have gained new understanding of how tumors metastasize by studying the behavior of exceptional breast and lung cancer cells that are capable of entering the brain and surviving there.
it means to survive cancer and learn how MSK is honoring all cancer survivors this year during National Cancer Survivor Month.